Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Code

Type your Poster Code, then hit apply

Showing 1,267 results.

Thumbnail for Treatment Outcomes and Prognostic Factors in Elderly Patients with Newly Diagnosed Peripheral T-Cell Lymphoma

TCL - 1326

Treatment Outcomes and Prognostic Factors in Elderly Patients with Newly Diagnosed Peripheral T-Cell Lymphoma

Omar Elghawy

Poster Presenter: Omar Elghawy

Thumbnail for State-Resolved Regulatory Profiling Identifies Product-Specific Transcription Factor and Pathway Activity in Axi-Cel and Tisa-Cel Infusion Products

CT - 1327

State-Resolved Regulatory Profiling Identifies Product-Specific Transcription Factor and Pathway Activity in Axi-Cel and Tisa-Cel Infusion Products

Trenton Gibson

Poster Presenter: Trenton Gibson

Previous 1...106 107 108 109 110 111 112...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Mortality, Thrombotic, Hemorrhagic, and Cardiovascular Outcomes With First-Line Carfilzomib Versus Bortezomib in Adults With Multiple Myeloma: A Real-World Propensity-Matched Analysis

MM - 1329

Mortality, Thrombotic, Hemorrhagic, and Cardiovascular Outcomes With First-Line Carfilzomib Versus Bortezomib in Adults With Multiple Myeloma: A Real-World Propensity-Matched Analysis

Chanchal Maheshwari

Poster Presenter: Chanchal Maheshwari

$Thumbnail for Prophylactic Tocilizumab To Reduce the Risk of CRS and ICANS in Patients With Relapsed/Refractory Multiple Myeloma Treated With Elranatamab$

MM - 1330

Prophylactic Tocilizumab To Reduce the Risk of CRS and ICANS in Patients With Relapsed/Refractory Multiple Myeloma Treated With Elranatamab

Corbin Wright

Poster Presenter: Corbin Wright

Thumbnail for Long-Term Mortality Trends and Disparities in Chronic Myeloid Leukemia Among Older Adults in the United States: A 1999-2024 CDC WONDER Analysis

CML - 1331

Long-Term Mortality Trends and Disparities in Chronic Myeloid Leukemia Among Older Adults in the United States: A 1999-2024 CDC WONDER Analysis

Adeel Khan

Poster Presenter: Adeel Khan

Thumbnail for Sensitivity Analyses of Symptom-Based Progression-Free Survival as a Composite Endpoint in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Results from the ALPINE Trial

CLL - 1333

Sensitivity Analyses of Symptom-Based Progression-Free Survival as a Composite Endpoint in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Results from the ALPINE Trial

Jennifer R. Brown

Poster Presenter: Jennifer R. Brown

Thumbnail for Multiple Myeloma Management in North Africa: Real-World Evidence and Outcomes From a 140 Patient Tunisian Cohort

MM - 1334

Multiple Myeloma Management in North Africa: Real-World Evidence and Outcomes From a 140 Patient Tunisian Cohort

Rahal Amira

Poster Presenter: Rahal Amira

Thumbnail for Obstructive Sleep Apnea and Outcomes After CAR-T Therapy in Diffuse Large B-Cell Lymphoma: A Real-World TriNetX Study

CT - 1335

Obstructive Sleep Apnea and Outcomes After CAR-T Therapy in Diffuse Large B-Cell Lymphoma: A Real-World TriNetX Study

Chander P Khatri

Poster Presenter: Chander P Khatri

$Thumbnail for Efficacy and Safety of Triplet Targeted Therapy for FLT3-Mutated Relapsed/Refractory AML: A Systematic Review and Proportion Meta-Analysis$

AML - 1336

Efficacy and Safety of Triplet Targeted Therapy for FLT3-Mutated Relapsed/Refractory AML: A Systematic Review and Proportion Meta-Analysis

Mehak Dang

Poster Presenter: Mehak Dang

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors